Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study FFR116364, a Double-blind, Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

NCT01630135 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01630135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01630135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study FFR116364, a Double-blind, Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
August 31, 2012
Enrollment
261 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, allergic, perennial